A unique collection of 157 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening. Target viruses include HBV, HCV, HIV, HSV, Influenza Virus, Reverse Transcriptase, etc. Bioactivity and?safety?confirmed by clinical research and trials, some of which are FDA approved; Detailed compound information with structure, target, activity, IC50 value, and biological activity description; Structurally diverse, medicinally active, and cell permeable; NMR and HPLC validated to ensure high purity and quality
